4//SEC Filing
Mahatme Ujwala 4
Accession 0001599298-22-000007
CIK 0001599298other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:05 PM ET
Size
8.0 KB
Accession
0001599298-22-000007
Insider Transaction Report
Form 4
Mahatme Ujwala
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-03+25,000→ 25,000 totalExercise: $2.82Exp: 2032-01-03→ Common Stock (25,000 underlying) - Award
Stock Option (right to buy)
2022-01-03$1.13/sh+47,872$54,095→ 72,872 totalExercise: $2.82Exp: 2032-01-03→ Common Stock (47,872 underlying)
Footnotes (4)
- [F1]The option was granted on January 3, 2022. The shares underlying the option are scheduled to vest in equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
- [F2]Not applicable.
- [F3]The option was issued on January 3, 2022. The shares underlying the option are scheduled to vest in four equal quarterly installments, on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022.
- [F4]The option was issued to the reporting person pursuant to the issuer's Director Retainer Option Election Plan in lieu of retainer fees of $54,000.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001823894
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:05 PM ET
- Size
- 8.0 KB